Case Report
Hepatitis B Virus Reactivation Induced by Infliximab Administration in a Patient with Crohn’s Disease
Table 1
Laboratory data on admission.
| Urine | | | BUN | 12.4 | mg/dL | Protein | | | Creatinine | 1.34 | mg/dL | Sugar | | | Na | 136 | mEq/L | Blood | | | K | 4.3 | mEq/L | Urobil. | | | Cl | 105 | mEq/L | | | | Ca | 8.1 | mg/dL | WBC | 4300 | /μL | Amylase | 169 | IU/L | RBC | | /μL | | | | Hb | 11.5 | g/dL | CRP | 3.75 | mg/dL | Ht | 33.1 | % | | | | Platelet | | /μL | PT | 89.1 | % | | | | PT (INR) | 1.05 | | T. protein | 6.4 | g/dL | | | | Alb. | 3.4 | g/dL | HBsAg | | CLIA | T. bil. | 0.3 | mg/dL | Anti-HBs | | CLIA | AST | 42 | IU/L | Anti-HBc | 1.62 | CLIA | ALT | 45 | IU/L | HBV-DNA | | Real-time PCR | ALP | 348 | IU/L | Anti-HCV | | CLIA | CHE | 238 | IU/L | | | | -GTP | 56 | IU/L | | | |
|
|
PCR: polymerase chain reaction; CLIA: chemiluminescence immunoassay.
|